Cholangiocarcinoma: New Insights

Document Type : Systematic Review and Meta-analysis

Author

Department of Gastroenterology, School of Medicine, Istanbul Medipol University, Istanbul, Turkey.

Abstract

 
Cholangiocarcinoma is a malignant neoplasm originating from biliary epithelial cells. The incidence and mortality of this cancer are rising in the world. Currently, cholangiocarcinoma is accepted as a stem cell disease with many risk factors. Diagnosis is relatively simple but therapy is extremely difficult. Surgery is the mainstay of treatment for early stage patients. Endobiliary approaches, chemotherapy and radiotherapy are other therapeutic approaches.

Keywords

Asian Pacific Journal of Cancer Prevention
Volume 18, Issue 6
June 2017
Pages 1469-1473

Files

History

  • Receive Date: 06 January 2017
  • Revise Date: 21 April 2017
  • Accept Date: 23 June 2017

Share

How to cite

Statistics